Virtual Reality Assistant for Prostate Cancer

CT
DG
Overseen ByDee Glaser-Boivin
Age: Any Age
Sex: Male
Trial Phase: Academic
Sponsor: Mayo Clinic
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a virtual reality assistant designed to support Black men recently diagnosed with prostate cancer. It provides emotional support, guidance on health-related issues, and tailored advice using AI and virtual reality. The trial specifically targets African American/Black men diagnosed with prostate cancer in the past two months who are patients at a participating clinic. Participants will use an app featuring a digital character to offer personalized support. The goal is to enhance care and resources for Black men facing prostate cancer. As an unphased trial, this study offers a unique opportunity to contribute to innovative support solutions for prostate cancer care.

Do I need to stop my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.

What prior data suggests that the Virtual Reality Assistant is safe for supporting prostate cancer patients?

Research has shown that virtual reality (VR) tools, like the one tested in this trial, are generally safe for patients. In previous studies, patients using immersive VR for cancer treatment reported positive experiences, with only a few experiencing dizziness or nausea. This suggests that the VR tool for prostate cancer is likely easy for users to handle. No reports of serious problems have emerged from using this type of VR tool. However, as with any new technology, monitoring individual reactions remains important.12345

Why are researchers excited about this trial?

Researchers are excited about the Virtual Reality Assistant (ViRA) treatment for prostate cancer because it offers a personalized and culturally tailored approach to patient care, which is a fresh take compared to traditional treatments like surgery, radiation, and hormone therapy. Unlike standard options, ViRA uses virtual reality technology to engage patients with interactive, digital human characters like cancer survivors or physicians, providing a more immersive and relatable experience. This innovative delivery method aims to empower patients, potentially improving their understanding and management of the disease, which could lead to better overall outcomes.

What evidence suggests that the ViRA intervention is effective for supporting Black men with prostate cancer?

Research shows that a virtual reality assistant (ViRA) can greatly help Black men newly diagnosed with prostate cancer. In this trial, one group of participants will receive immediate access to the ViRA app, while another group will receive standard care followed by delayed access to the app. Studies have found that this tool can boost emotional well-being by offering personalized and culturally relevant support. The ViRA app uses artificial intelligence to provide advice and guidance through a digital character, such as a cancer survivor or doctor, making the information more relatable. This method addresses the specific needs of Black men and may help close the gap in prostate cancer care. Early results suggest that this approach is promising in providing important emotional and educational support.12678

Who Is on the Research Team?

FT

Folakemi T. Odedina, PhD

Principal Investigator

Mayo Clinic

Are You a Good Fit for This Trial?

This trial is for newly diagnosed Black men with prostate cancer, aiming to support them through a virtual reality assistant. It focuses on providing psycho-oncology support, health navigation, and emotional assistance using AI and augmented reality.

Inclusion Criteria

I agree to participate in the study.
Be a patient at a participating clinic or affiliates with one of our community sites
I am an African American/Black male diagnosed with prostate cancer within the last two months.

Exclusion Criteria

Do not speak or understand English
Unable to read or write

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive access to the ViRA app and are presented with short screening questions, which an AI engine uses to recommend personalized and culturally tailored VR ready CaP interventions.

3 months
Weekly virtual interactions

Follow-up

Participants are monitored for emotional support, social determinants of health navigation, and psycho-oncology support.

12 months
Follow-up at 1, 3, 6, 9, and 12 months

What Are the Treatments Tested in This Trial?

Interventions

  • Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention
Trial Overview The intervention being tested is a Virtual Reality Assistant (ViRA) designed to help manage the challenges faced by Black men at the point of prostate cancer diagnosis. The study evaluates its effectiveness in offering educational and emotional support.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Group I: Arm II (ViRA application)Experimental Treatment3 Interventions
Group II: Arm I (delayed-start intervention [ViRA application])Experimental Treatment4 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

Mayo Clinic

Lead Sponsor

Trials
3,427
Recruited
3,221,000+

Citations

A Point of Prostate Cancer Diagnosis Virtual Reality ...This clinical trial tests how well a point of prostate cancer diagnosis (PPCD) virtual reality assistant (ViRA) intervention works in supporting Black men ...
A Study Of Prostate Cancer Diagnosis Virtual Reality ...The purpose of this study is to evaluate the effectiveness of the PPCD ViRA on the delivery of PPCD support in a clinic setting, at home and community setting; ...
Virtual Reality Assistant for Prostate Cancer Support ...Throughout the study, participants' emotional well-being and other outcomes are monitored at several intervals to assess the effectiveness of the intervention.
Virtual Reality Assistant for Prostate CancerThis clinical trial tests how well a point of prostate cancer diagnosis (PPCD) virtual reality assistant (ViRA) intervention works in supporting Black men ...
Abstract B028: A point of prostate cancer diagnosis (PPCD ...The specific aim of our project is to develop a PPCD-based Augmented Reality (AR) intervention program, the iCCaRE PPCD Virtual Robot Assistant (ViRA).
Virtual Health Assistants in Preventive Cancer Care ...We focus on cancer prevention and screening because a lack of audience-centered communication can drastically change the outcome of a patient's ...
(PDF) Virtual reality-based training for the diagnosis of ...Prostate malignancies are the second leading cause of cancer deaths among men. The most common method of detecting this disease is digital ...
Immersive Virtual Reality Experience of Patients with ...The patients' experience with iVR was positive and enhanced their experience of receiving antineoplastic infusion therapy, with minimal cybersickness.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security